Full name
ORTOCAST SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
70.10.Z - Head office activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.99.Z - Retail trade
70.22.Z - Head office activities and management consultancy
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -1,5 | 0 | 0 | 0 |
EBITDA | -1,5 | 0 | 0 | 0 |
Short time liabilities | 7,2 | 3 | 3 | 0 |
Equity capital | -3 | 0,4 | 0,3 | -16,8 |
Operating profit (EBIT) | -1,5 | 0 | 0 | 0 |
Assets | 4,2 | 0,2 | 0,2 | 0 |
Net profit (loss) | -1,5 | 0 | 0 | 0 |
Cash | 4 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 7,2 | 3 | 3 | 0 |
Working assets | 4 | 0,2 | 0,2 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 49,1 | 0 | 0 | 0 |
Equity capital to total assets | -70,9 | 205,5 | 171 | -34,5 |
Gross profit margin | 1,9 | |||
EBITDA Margin | 1,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.5575200319290161 | 0.06659296900033951 | 0.06659296900033951 | 0 |
Net dept to EBITDA | 2.7358205318450928 | 28,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane